Khosla Ventures
Listed as “Moonwalk Biosciences”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Company website description: By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies…
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Moonwalk Biosciences”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.